Why the study?
Due to the high prevalence of depression and depressive symptoms in post-MI patients, assessing its prognostic importance and clarifying whether symptoms relate to the underlying disease or concomitant depression was needed.
Evaluating and treating depressive symptoms in post-MI patients is important for improving their quality of life.
Integrating depression screening into post-MI care may enhance quality of life; leaves open whether targeted.
Patients with myocardial infarction (MI) have both major depression as well as depressive symptoms. Therefore, due to the high prevalence of depression in post-MI patients, an assessment of its prognostic importance was put on the agenda. Patients after ACS frequently report fatigue, sleep problems, and sadness. Evaluation of these symptoms is very important because it should be clarified whether these symptoms are related only to the main disease or they indicate the presence of concomitant depression. Given a high predictive value of somatic-affective symptoms, it is recommended to assess them in post-MI patients. Further treatment of somatic and cognitive-affective symptoms of depression will improve the quality of life of patients with acute coronary events.
No takes yet. Share an insight, caveat, or question.
Tatishvili et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: